We recently compiled a list of the 12 Best Software Stocks to Buy According to Analysts. In this article, we are going to ...

Vertex Pharmaceuticals Inc. closed 18.83% below its 52-week high of $519.88, which the company achieved on November 8th.

A look at Intellia Therapeutics, Inc. and Editas Medicine, Inc., including their restructuring and pipeline prioritization.

Netflix is set to report fourth-quarter results after the closing bell on Tuesday, with Wall Street analysts holding mostly ...

CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

(RTTNews) - EPAM Systems, Inc. (EPAM), Wednesday announced an expansion of its partnership with Google Cloud to deliver innovative industry solutions. The collaboration, with the support of Google ...

Vertex (VRTX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report)‘s stock had its “outperform” rating reaffirmed by stock analysts at ...

Can you solve it faster than others? Billionaire Investor Bill Ackman Just Went All In On One of His Favorite Stocks: He ...

Blueprint Medicines' Ayvakit shows strong revenue growth, projected to reach over $2 billion in peak sales. Read my analysis ...

InvestingPro's Fair Value analysis suggests the stock is currently overvalued, despite maintaining a GOOD Financial Health Score. For deeper insights into Vertex's valuation and 12+ additional ProTips ...